GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elanix Biotechnologies AG (FRA:ELN) » Definitions » Price-to-Operating-Cash-Flow

Elanix Biotechnologies AG (FRA:ELN) Price-to-Operating-Cash-Flow : (As of May. 28, 2024)


View and export this data going back to . Start your Free Trial

What is Elanix Biotechnologies AG Price-to-Operating-Cash-Flow?

As of today (2024-05-28), Elanix Biotechnologies AG's share price is €0.053. Elanix Biotechnologies AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2018 was €-0.33. Hence, Elanix Biotechnologies AG's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Elanix Biotechnologies AG's Price-to-Operating-Cash-Flow or its related term are showing as below:

FRA:ELN's Price-to-Operating-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 16.85
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Elanix Biotechnologies AG's Cash Flow from Operations per share for the six months ended in Dec. 2018 was €0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2018 was €-0.33.


Elanix Biotechnologies AG Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Elanix Biotechnologies AG's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elanix Biotechnologies AG Price-to-Operating-Cash-Flow Chart

Elanix Biotechnologies AG Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Elanix Biotechnologies AG Semi-Annual Data
Dec08 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Elanix Biotechnologies AG's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Elanix Biotechnologies AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elanix Biotechnologies AG's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elanix Biotechnologies AG's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Elanix Biotechnologies AG's Price-to-Operating-Cash-Flow falls into.



Elanix Biotechnologies AG Price-to-Operating-Cash-Flow Calculation

Elanix Biotechnologies AG's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.053/-0.334
=

Elanix Biotechnologies AG's Share Price of today is €0.053.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Elanix Biotechnologies AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2018 was €-0.33.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Elanix Biotechnologies AG Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Elanix Biotechnologies AG's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Elanix Biotechnologies AG (FRA:ELN) Business Description

Traded in Other Exchanges
N/A
Address
Street-4, Georg-Glock, c/o HEUKING KÜHN LÜER WOJTEK, Dusseldorf, NW, DEU, 40474
Elanix Biotechnologies AG is a tissue regeneration company. It develops and commercializes products for acute wound care, dermatological and gynecological applications as well as providing cell technology services. The company's operating segment include Regenerative Medicine and Cosmetic ointments. It generates maximum revenue from the Cosmetic ointments segment. Geographically, it derives a majority of revenue from Switzerland and also has a presence in the EU, and Taiwan.

Elanix Biotechnologies AG (FRA:ELN) Headlines

No Headlines